BioSyent, Inc. (RX.V)
15.55
-0.15
(-0.96%)
CAD |
TSXV |
Aug 26, 11:44
BioSyent Total Liabilities (Quarterly) : 14.62M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.62M |
| March 31, 2026 | 17.50M |
| December 31, 2025 | 7.974M |
| September 30, 2025 | 7.882M |
| June 30, 2025 | 5.895M |
| March 31, 2025 | 6.750M |
| December 31, 2024 | 6.356M |
| September 30, 2024 | 8.124M |
| June 30, 2024 | 6.060M |
| March 31, 2024 | 5.444M |
| December 31, 2023 | 6.769M |
| September 30, 2023 | 6.846M |
| June 30, 2023 | 6.443M |
| March 31, 2023 | 5.329M |
| December 31, 2022 | 7.123M |
| September 30, 2022 | 6.020M |
| June 30, 2022 | 5.252M |
| March 31, 2022 | 5.842M |
| December 31, 2021 | 5.612M |
| September 30, 2021 | 6.993M |
| June 30, 2021 | 5.534M |
| March 31, 2021 | 5.502M |
| December 31, 2020 | 6.775M |
| September 30, 2020 | 5.759M |
| June 30, 2020 | 5.461M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.490M |
| December 31, 2019 | 5.171M |
| September 30, 2019 | 4.633M |
| June 30, 2019 | 3.238M |
| March 31, 2019 | 3.057M |
| December 31, 2018 | 3.583M |
| September 30, 2018 | 2.818M |
| June 30, 2018 | 3.130M |
| March 31, 2018 | 2.491M |
| December 31, 2017 | 2.892M |
| September 30, 2017 | 2.287M |
| June 30, 2017 | 2.363M |
| March 31, 2017 | 2.088M |
| December 31, 2016 | 2.522M |
| September 30, 2016 | 1.731M |
| June 30, 2016 | 2.130M |
| March 31, 2016 | 1.511M |
| December 31, 2015 | 2.456M |
| September 30, 2015 | 1.989M |
| June 30, 2015 | 1.844M |
| March 31, 2015 | 1.690M |
| December 31, 2014 | 2.485M |
| September 30, 2014 | 1.809M |
| June 30, 2014 | 1.299M |
| March 31, 2014 | 0.9721M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 104.01M |
| Bausch Health Cos., Inc. | 36.31B |
| Cipher Pharmaceuticals, Inc. | 27.86M |
| Revive Therapeutics Ltd. | 4.306M |
| Knight Therapeutics, Inc. | 246.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.46M |
| Shareholders Equity (Quarterly) | 45.84M |
| Debt to Equity Ratio | 0.0685 |
| Current Ratio | 2.068 |
| Net Debt Paydown Yield | -0.26% |